EVALUATION OF CURRENT CLINICAL MODELS FOR RISK OF PROGRESSION FROM SMOLDERING MULTIPLE MYELOMA TO MULTIPLE MYELOMA IN 287 PATIENTS FOLLOWED IN THE CZECH REPUBLIC

EHA Library, ROMAN HAJEK, 100798

VENETOCLAX (ABT-199/GDC-0199) MONOTHERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: PHASE I SAFETY AND EFFICACY

EHA Library, Shaji Kumar, 100799

IMPACT OF FISH ABNORMALITIES ON RISK OF PROGRESSION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE

EHA Library, Shaji Kumar, 100800

POST RELAPSE OUTCOMES IN YOUNG PATIENTS WITH MULTIPLE MYELOMA IN THE ERA OF NOVEL AGENTS

EHA Library, Prashant Kapoor, 100801

SKY92 GEP, IFISH AND ISS COMPARISONS FOR RISK STRATIFICATION IN MULTIPLE MYELOMA

EHA Library, Erik van Beers, 100802

MARKERS OF DISEASE EVOLUTION IN SMOLDERING MULTIPLE MYELOMA (SMM)

EHA Library, Eftychia Nikolaou, 100803

EFFICIENCY AND TOXICITY OF CYCLOPHOSPHAMIDE BASED STEM CELL MOBILIZATION IN RELAPSED MULTIPLE MYELOMA PATIENTS: OBSERVATIONS FROM THE ONGOING PHASE III TRIAL RELAPSE

EHA Library, Marc-A. Baertsch, 100804

HEAVY LIGHT CHAIN RATIO NORMALIZATION ALLOWS IDENTIFICATION OF ELECTROPHORETIC NON-COMPLETE RESPONSE PATIENTS WITH IMPROVED OUTCOMES: A LONG TERM FOLLOW UP UPDATE FOR BMT CTN 0102 CORRELATIVE STUDY.

EHA Library, Anita D'Souza, 100805

CLINICAL IMPACT OF BONE MARROW MORPHOLOGY FOR THE DIAGNOSIS OF ESSENTIAL THROMBOCYTHEMIA: COMPARISON BETWEEN THE BRITISH STANDARDS (BCSH) AND THE WHO CRITERIA

EHA Library, Georg Jeryczynski, 100806

MYELOPROLIFERATIVE NEOPLASMS AND INFECTIONS; A POPULATION-BASED STUDY ON 9,665 PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS DIAGNOSED IN SWEDEN 1987-2009

EHA Library, Malin Hultcrantz, 100807

UNFAVORABLE KARYOTYPE AND MOLECULAR NEGATIVITY SIGNIFICANTLY INFLUENCE THE INFECTIOUS RISK IN MYELOFIBROSIS: EVALUATION ON 426 PATIENTS

EHA Library, Nicola Polverelli, 100808

PRIMARY MYELOFIBROSIS, POST-ET AND POST-PV MYELOFIBROSIS HAVE DISTINCT CLINICAL PROFILES AND SYMPTOMATIC BURDENS: AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP (MPN-QOL ISG)

EHA Library, Holly L Geyer, 100809

IMPACT OF CALR AND ASXL1 MUTATIONS ON SURVIVAL AND DISEASE COMPLICATIONS IN ESSENTIAL THROMBOCYTHEMIA AND PREFIBROTIC PRIMARY MYELOFIBROSIS STRICTLY DIAGNOSED ACCORDING TO THE WHO-CLASSIFICATION

EHA Library, Heinz Gisslinger, 100810

RUXOLITINIB PROVIDES CONSISTENT HEMATOCRIT CONTROL IN PATIENTS WITH POLYCYTHEMIA VERA (PV) RESISTANT TO OR INTOLERANT OF HYDROXYUREA

EHA Library, Martin Griesshammer, 100811

PHASE 2 STUDY OF A NOVEL CONTROLLED-RELEASE FORMULATION OF ANAGRELIDE (GALE-401) IN SUBJECTS WITH MYELOPROLIFERATIVE NEOPLASM (MPN)-RELATED THROMBOCYTOSIS

EHA Library, Nasiema Wingate-Pearse, 100812

SAFETY OF RUXOLITINIB IN PATIENTS WITH POLYCYTHEMIA VERA: RESULTS FROM THE CLINICAL TRIAL PROGRAM

EHA Library, Srdan Verstovsek, 100813

EFFECT OF RUXOLITINIB ON MARKERS OF IRON DEFICIENCY: AN ANALYSIS OF THE RESPONSE TRIAL

EHA Library, Srdan Verstovsek, 100814

RUXOLITINIB REDUCES JAK2P.V617F ALLELE BURDEN IN PATIENTS WITH MYELOFIBROSIS

EHA Library, Srdan Verstovsek, 100815

SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN PATIENTS WITH INTERMEDIATE-1–RISK MYELOFIBROSIS (MF) FROM AN OPEN-LABEL, MULTICENTER, SINGLE-ARM EXPANDED-ACCESS STUDY

EHA Library, Pilar Giraldo, 100816

INTERIM ANALYSIS OF A PHASE II PILOT TRIAL OF RUXOLITINIB COMBINED WITH DANAZOL FOR PATIENTS WITH MYELOFIBROSIS SUFFERING FROM ANEMIA

EHA Library, Ruben Mesa, 100817

BONE MARROW FIBROSIS BY WHO GRADE AND QUANTITATIVE IMAGE ANALYSIS IS REDUCED BY PRM-151 IN PATIENTS WITH MYELOFIBROSIS AND ASSOCIATED WITH IMPROVED BONE MARROW MORPHOLOGY AND INCREASED PLATELET COUNTS

EHA Library, Olga Pozdnyakova, 100818

THE ITALIAN MASTOCYTOSIS REGISTRY: THE FIRST FIVE YEARS

EHA Library, Serena Merante, 100819

HIGH RATE OF DISCORDANCY REGARDING DIAGNOSIS AND SUBCLASSIFICATIONOF SYSTEMIC MASTOCYTOSIS ON BONE MARROW BIOPSIESBETWEEN INITIAL LOCAL AND CENTRALIZED REFERENCE HEMATOPATHOLOGY

EHA Library, Mohamad Jawhar, 100820

CLINICAL AND MOLECULAR CHARACTERISTICS OF PATIENTS WITH SYSTEMIC MASTOCYTOSIS AND ASSOCIATED ACUTE MYELOID LEUKAEMIA

EHA Library, Sebastian Kreil, 100821

VALIDATION OF THE SIMPLIFIED PROGNOSTIC SCORE FOR SMZL OF THE SMZLSG (SMZL STUDY GROUP) IN A SERIES OF PATIENTS TREATED WITH RITUXIMAB MONOTHERAPY, AND LONG TERM OUTCOME OF RITUXIMAB RESPONDERS

EHA Library, Christina Kalpadakis, 100822

INCIDENCE OF TRANSFORMATION IN FOLLICULAR LYMPHOMA: MULTICENTRE RETROSPECTIVE ANALYSIS OF THE SPANISH GROUP OF LYMPHOMA AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (GELTAMO)

EHA Library, Miguel Alcoceba, 100823

PROSPECTIVELY DEFINED TRIAL- (N=13) AND PATIENT- (N=3837) LEVEL ANALYSIS OF COMPLETE RESPONSE RATES AS SURROGATE ENDPOINTS FOR PROGRESSION-FREE SURVIVAL (PFS) IN FIRST-LINE FOLLICULAR LYMPHOMA (FL)

EHA Library, Daniel Sargent, 100824

MYD-88 L265P IN A SERIES OF CD5(-) CLONAL B-CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CD5- CBL)

EHA Library, Christina Kalpadakis, 100825

EFFICACY AND SAFETY OF R-COMP REGIMEN IN NON HODGKIN LYMPHOMA PATIENTS WITH CARDIOVASCULAR COMORBIDITIES.

EHA Library, Ombretta Annibali, 100826

THE EFFECTIVENESS OF ANTIVIRAL THERAPY IN PATIENTS WITH HEPATITIS C ASSOCIATED INDOLENT LYMPHOMA (IL + C)

EHA Library, sergey lepkov, 100827

COMPARISON OF SUBCUTANEOUS AND INTRAVENOUS RITUXIMAB IN THE MAINTENANCE SETTING: UPDATED SAFETY RESULTS OF THE PHASE III SABRINA STUDY IN PATIENTS WITH FOLLICULAR LYMPHOMA

EHA Library, Andrew J. Davies, 100828

TWO DOSES OF POLATUZUMAB VEDOTIN (POV, ANTI-CD79B ANTIBODY-DRUG CONJUGATE) PLUS RITUXIMAB (R) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): DURABLE RESPONSES AT LOWER DOSE LEVEL

EHA Library, Jeff Sharman, 100829

IDELALISIB EFFICACY AND SAFETY IN FOLLICULAR LYMPHOMA PATIENTS FROM A PHASE 2 STUDY

EHA Library, Pier Luigi Zinzani, 100830

IDELALISIB MONOTHERAPY RESULTS IN DURABLE RESPONSES IN PATIENTS WITH RELAPSED OR REFRACTORY WALDENSTROM’S MACROGLOBULINEMIA (WM)

EHA Library, Steven E Coutre, 100831

RECURRENT TP53 ALTERATIONS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Jessica Hoell, 100832

MESENCHYMAL STROMAL CELLS STIMULATE PROLIFERATION AND CYTOKINE PRODUCTION OF GROUP 3 INNATE LYMPHOID CELLS

EHA Library, Marius Munneke, 100833

ENDOTHELIAL CELL MICROPARTICLES-DELIVERY MIR-155 PROMOTES THE DEVELOPMENT OF AGVHD BY MODULATING T CELLS

EHA Library, Qiuling Wu, 100834

PRESENCE OF KIR2DS1 RECEPTOR IN DONORS OF ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION DUE TO MYELOID MALIGNANCIES IMPROVES OVERALL SURVIVAL IN RECIPIENTS WITH HLA-C2 ANTIGENS

EHA Library, Attila Tordai, 100835

ENDOTHELIAL MICROPARTICLE IS INVOLVED IN THE DEVELOPMENT OF ACUTE GVHD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Mei Hong, 100836

SIMPLE, EFFICIENT, AND SAFE PROCESSING OF FROZEN-THAWED UMBILICAL CORD-DERIVED MESENCHYMAL STROMAL CELLS APPLIED FOR THE TREATMENT OF GVHD

EHA Library, Tokiko Nagamura-Inoue, 100837

THE IMPACT OF NFAT INHIBITION ON NEUTROPHIL EFFECTOR FUNCTIONS IN PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Daniel Teschner, 100838

INHIBITION OF TRANSFORMING GROWTH FACTOR ΒETA-ACTIVATED KINASE 1 SUPPRESSES ALLOREACTIVITY AND IMPROVES SURVIVAL IN A MURINE MARROW TRANSPLANTATION MODEL

EHA Library, Ayako Kobayashi, 100839

DISTINCT EXOSOMAL MIRNA EXPRESSION OF LATE ONSET GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Seiichiro Yoshizawa, 100840

B LYMPHOCYTES ARE IMPORTANT EFFECTOR CELLS IN ANTI-AML RESPONSES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Marijn Gillissen, 100841

FEMUR TARGET CELL TRANSPLANTATION CAN BE ACHIEVED BY MAGNETISM-INDUCED CELL TARGET TRANSPLANTATION (MAGIC-TT) IN MURINE TRANSPLANTATION MODEL

EHA Library, Hao Huang, 100842

COMPLEMENT-BINDING DONOR-SPECIFIC ANTI-HLA ANTIBODIES AND RISK OF PRIMARY GRAFT FAILURE IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Stefan Ciurea, 100843

DURABLE REMISSIONS AFTER SEQUENTIAL TRANSPLANTATION USING T-REPLETE NON-MYELOABLATIVE CONDITIONING FOR RELAPSED/ REFRACTORY ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASIA

EHA Library, Sandra hassan, 100844

SERUM FERRITIN IS INDEPENDENT OF DISEASE RISK INDEX FOR OVERALL SURVIVAL FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Lynette Chee, 100845

COMBINATION THERAPY WITH INOLIMOMAB AND ETANERCEPT FOR SEVERE STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Lenneke van groningen, 100846

PURE RED CELL APLASIA IN MAJOR ABO MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ASSOCIATED WITH SEVERE PANCYTOPENIA

EHA Library, Fleur Aung, 100847

DONOR CHIMERISM AS MARKER OF RELAPSES AFTER BONE MARROW TRANSPLANTATION.

EHA Library, Ildar Barkhatov, 100848

PERIPHERAL BLOOD EOSINOPHIL COUNT AT DAY 28 AS A PROGNOSTIC INDICATOR IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Keisuke Kawamoto, 100849

AUTOLOGOUS STEM CELL TRANSPLANTATION WITH HIGH-DOSE MITOXANTRONE AND MELPHALAN IN PATIENTS WITH HODGKIN AND NON-HODGKIN LYMPHOMA : LONG-TERM SURVIVAL AND TOXICITY DATA

EHA Library, Yener Koc, 100850

RISK FACTORS FOR TRANSPLANTATION-ASSOCIATED THROMBOTIC MICROANGIOPATHY AND OUTCOME OF PATIENTS, FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Katalin Balassa, 100851

REITERATED THERAPEUTIC DRUG MONITORING (TDM) TO BETTER CONTROL TARGETED EXPOSURE TO IV BUSULFAN IN INFANTS AND OLDER CHILDREN UNDERGOING HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT)

EHA Library, Alexandre Amin, 100852

FACTORS DETERMINING THE EFFECTIVENESS OF ACUTE GRAFT VERSUS HOST DISEASE PROPHYLAXIS AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION WITH MULTIPOTENT MESENCHYMAL STROMAL CELLS

EHA Library, Nataliya Petinati, 100853

IMPACT OF HISTOLOGIC GRADE ON THE OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMAS

EHA Library, Paolo Corradini, 100854

ALPHA/BETA T-CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION FROM MATCHED RELATED AND UNRELATED DONOR GRAFTS IN PATIENTS WITH HIGH RISK HEMATOLOGICAL MALIGNANCIES.

EHA Library, Moniek de Witte, 100855

OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT IN PATIENTS WITH MDS/MPN OVERLAP SYNDROMES- A SINGLE INSTITUTIONAL EXPERIENCE.

EHA Library, Shivani Shinde, 100856

FEASIBILITY OF LENALIDOMIDE MAINTENANCE AFTER NONMYELOABLATIVE ALLOGENEIC TRANSPLANTATION (NMAT) IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL).

EHA Library, Issa Khouri, 100857

ENGRAFTMENT SYNDROME (ES) AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A HIGH INCIDENCE IN HAPLOIDENTICAL SETTING

EHA Library, Yao Chen, 100858

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PLERIXAFOR + G-CSF VS PLACEBO + G-CSF TO MOBILIZE ≥5 X 106 CD34+ CELLS/KG IN CHINESE NHL PATIENTS FOR AUTOLOGOUS TRANSPLANTATION

EHA Library, Jun Zhu, 100859

INFLUENCE OF CYP3A5 GENE POLYMORPHISMS ON PHARMACOKINETICS OF TACROLIMUS MODIFIED-RELEASE ONCE-DAILY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Takaya Yamashita, 100860

INTERFERONΑ: A POTENTIAL EFFECTIVE TREATMENT FOR MINIMAL RESIDUAL DISEASE IN ACUTE LEUKEMIA/MYELODYSPLASTIC SYNDROME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiao-Dong Mo, 100862

INCIDENCE, RISK FACTORS, AND OUTCOME OF EARLY HEMOSTATIC COMPLICATIONS IN PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE MULTICENTER STUDY OF 551 PATIENTS

EHA Library, Yue Han, 100863

A PROSPECTIVE CLINICAL TRIAL OF PROLONGED AUTOLOGOUS ERYTHROPOIETIN (EPO) SECRETION FROM TARGTEPO IN EPO-DEPENDENT END STAGE RENAL DISEASE PATIENTS SHOWED EPO INDEPENDENCE FOR OVER 8 MONTHS

EHA Library, Shany Blum, 100864

ADOPTIVE IMMUNOTHERAPY OF MULTIPLE MYELOMA (MM) WITH ALLOGENIC CAR T-CELLS TARGETING CS1: ENHANCEMENT OF CAR ACTIVITY THROUGH CS1 GENE INACTIVATION IN EFFECTOR CELLS

EHA Library, Roman Galetto, 100865

EVALUATING HUMAN T-CELL THERAPY OF CYTOMEGALOVIRUS ORGAN DISEASE IN HLA-TRANSGENIC MICE

EHA Library, Simone Thomas, 100866

NOVEL HUMAN IL-15 SUPERAGONIST PROMOTES LONG-TERM PERSISTENCE AND REACTIVITY OF HUMAN EBV- AND LEUKEMIA-SPECIFIC CD8+ T CELLS WITH STEM CELL MEMORY AND CENTRAL MEMORY PROPERTIES IN HUMANIZED MICE.



EHA Library, Udo Hartwig, 100867

DENDRITIC CELL VACCINATION IN POSTREMISSION THERAPY OF AML: RESULTS OF A CLINICAL PHASE I TRIAL AND OF PRECLINICAL STUDIES TESTING COMBINATORIAL APPROACHES

EHA Library, Marion Subklewe, 100868

COMBINATION OF IBRUTINIB AND ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF RELAPSING/REFRACTORY MANTLE CELL LYMPHOMA (MCL)

EHA Library, Marco Ruella, 100869

INTERIM ANALYSIS OF PHASE I/II TRIAL IN HIGH-RISK PEDIATRIC PATIENTS POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) TREATED WITH EX VIVO EXPANDED DONOR-DERIVED ADENOVIRUS-SPECIFIC T CELLS

EHA Library, Winnie Ip, 100870

LIPOSOME-BASED SPECIFIC TARGETING OF A STAT3-INHIBITOR TO CANCER-PROMOTING MACROPHAGES: A NOVEL THERAPUTIC PARADIGM IN MULTIPLE MYELOMA

EHA Library, Morten Nørgaard Andersen, 100871

ANTIBODY-TARGETED CYCLODEXTRIN NANOPARTICLES DELIVER SIRNA AND ACHIEVE THERAPEUTIC GENE SILENCING IN BLOOD FROM ACUTE MYELOID LEUKAEMIA (AML) PATIENTS

EHA Library, Jianfeng Guo, 100872

CLINICAL GRADE ACTIVATED NATURAL KILLER PRODUCTS FOR ADOPTIVE IMMUNOTHERAPY AGAINST HIGH-RISK MALIGNANCIES

EHA Library, Antonio Perez, 100873

IMPROVED SAFETY AND EFFICACY OF A HIGH-AFFINITY A2.1-RESTRICTED SINGLE-CHAIN P53-SPECIFIC TCR FOR ADOPTIVE IMMUNOTHERAPY

EHA Library, Hakim Echchannaoui, 100874

HYDROXYUREA FOR Β-THALASSEMIA: A META-ANALYSIS

EHA Library, Ali Algiraigri, 100875

PHENOTYPIC VARIATIONS IN SICKLE CELL DISEASE: AN EXPLORATION OF THE ROLE OF THE ENVIRONMENT AND SKIN MICROBIOME ON LEG ULCERS

EHA Library, Caterina Minniti, 100876

PERICARDIAL EFFUSION IS A MARKER OF INCREASED CARDIAC MORTALITY IN THALASSEMIA MAJOR PATIENTS

EHA Library, Alessia Pepe, 100877

OUTCOMES OF A COHORT OF CHILDREN WITH HEMOGLOBINOPATHY RECEIVING ORAL IRON CHELATORS FOR TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN TURKEY: RESULTS OF 3-YEAR FOLLOW-UP STUDY

EHA Library, Ali Bülent Antmen, 100878

RARE INHERITED ANAEMIAS: A CLINICAL-GRADE VALIDATED TARGETED RESEQUENCING PANEL YIELDS HIGH DIAGNOSTIC RATES AND IMPROVES TARGETED MANAGEMENT

EHA Library, Noemi , 100879

A PROSPECTIVE CROSS-SECTIONAL STUDY ON OPTHALMOLOGIC COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE IN LEBANON

EHA Library, Adlette Inati, 100880

PREVALENCE OF G6PD DEFICIENCY IN PATIENTS WITH SICKLE CELL DISEASE AND IMPACT ON DISEASE SEVERITY IN LEBANON

EHA Library, Adlette Inati, 100881

ANTIFUNGAL PROPHYLAXIS IN HAEMATOLOGY PATIENTS: FREQUENCY AND DRUG CLASS OF CHOICE ACCORDING TO TYPE OF HAEMATOLOGICAL MALIGNANCY (AFHEM STUDY)

EHA Library, Mauricette Michallet, 100882

INVESTIGATING CYTOPENIA MAY REVEAL BONE MARROW METASTASIS: A SINGLE CENTER EXPERIENCE FROM THE HEMATOPATHOLOGIST POINT OF VIEW

EHA Library, Ambra Paolini, 100883

DORIPENEM VERSUS MEROPENEM AS THE FIRST-LINE MONO-THERAPY IN HIGH-RISK FEBRILE NEUTROPENIC PATIENTS WITH ACUTE LEUKEMIA: A RANDOMIZED, CONTROLLED TRIAL

EHA Library, Norifumi Sugawara, 100884

THE RATE OF HUMAN HERPES VIRUS 6 INFECTION IN ACUTE LEUKEMIA AND LYMPHOMA PATIENTS

EHA Library, Tatiana Lobanova, 100885

IMPACT OF DECTIN-1 POLYMORPHISMS ON SUSCEPTIBILITY OF INVASIVE FUNGAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Mike Fischer, 100886

ANTIFUNGAL PROPHYLAXIS WITH POSACONAZOLE IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME PATIENTS TREATED WITH INTENSIVE CHEMOTHERAPY. A MULTICENTER RETROSPECTIVE STUDY OF REAL-LIFE PRACTICE

EHA Library, David Serrano, 100887

COMMUNITY ACQUIERED RESPIRATORY VIRUS IN ADULTS PATIENTS WITH HEMATOLOGICAL DISEASE: CLINICAL CHARACTERISTICS AND OUTCOME IN RSV AND HPIV INFECTION

EHA Library, ALICIA LORENZO JAMBRINA, 100888

LEVEL OF PENTRAXIN-3 IN PATIENTS WITH ACUTE LEUKEMIA IN SEPTICEMIA AND ITS PROGNOSTIC VALUE

EHA Library, Mohamed El-defrawy, 100889

IDENTIFICATION OF CLONALITY IN IDIOPATHIC HYPEREOSINOPHILIA USING TARGETED EXOME SEQUENCING

EHA Library, Jee-Soo Lee, 100890

DEVELOPMENT OF A NOVEL ANTI-NEUTROPENIC FACTOR CLINICAL CANDIDATE FOR HEMATOPOIESIS DEFICIENCIES

EHA Library, Ronald Jubin, 100891

PRECLINICAL PHARMACOKINETIC/PHARMACODYNAMIC RELATIONSHIPS FOR AG-348, AN INVESTIGATIONAL SMALL-MOLECULE ACTIVATOR OF PYRUVATE KINASE

EHA Library, Yue Chen, 100892

EFFICACY AND SAFETY OF ELTROMBOPAG IN PATIENTS WITH MODERATE, SEVERE AND VERY SEVERE APLASTIC ANEMIA

EHA Library, Danielle Nance, 100893

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: SINGLE CENTER EXPERIENCE

EHA Library, Ersin Toret, 100894

MANAGEMENT OF CYCLIC NEUROPENIA: DIAGNOSIS AND THERAPY

EHA Library, Cornelia Zeidler, 100895

RELATION BETWEEN GLUTATHIONE S TRANSFERASE GENES (GSTM1, GSTT1 AND GSTP1) POLYMORPHISMS AND CLINICAL MANIFESTATIONS OF SICKLE CELL DISEASE IN EGYPTIAN PATIENTS

EHA Library, Hend Ellithy, 100896

CASES OF SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS:A SINGLE CENTER EXPERIENCE.

EHA Library, Serap Karaman, 100897

MYCHOPHENOLATE MOFETIL AND SIROLIMUS AS TREATMENT OF AUTOIMMUNE LYMPHOPROLIFERATIVE DISEASE IN CHILDREN: A SINGLE CENTER EXPERIENCE

EHA Library, Maurizio Miano, 100898